Low-Friction Coating Speeds Filling of Pharmaceutical Vials

One of the primary challenges for pharmaceutical filling lines is the prevention of damage and disruption to the flow of vials, which can result in expensive recalls and increased manufacturing costs. To address these concerns, SGD Pharma has introduced a new range of Type I tubular vials with Corning’s friction-reducing and stabilizing outer coating to help manufacturers optimize their fill-and-finish operations.

The new vials reduce the frictional resistance created by glass-to-glass and glass-to-metal contact, thereby helping pharmaceutical filling lines prevent potential disruptions, including tip-overs, jams, and glass breakages.

According to SGD Pharma, the new vials reduce the total cost of ownership and improve glass quality, making the fill-and-finish process 20% to 50% more efficient. The vials also improve patient safety by reducing the risk of vial cracks and glass particle contamination. The company claims that pharmaceutical customers will see a reduction in glass particulates of up to 96%. This will protect the end user from particulates trapped inside vials and improve product quality and safety.

SGD Pharma’s Velocity vials are compliant with USP and EP requirements and are manufactured and released in accordance with ISO GMP standards. The Velocity vial coating technology is available in both clear and amber glass, in standard vial sizes 2R to 20R (sizes up to 30R can be made available on request) and is compliant with EU and US health authorities.